Inventors with similar research interests:
Location History:
- Menands, NY (US) (1991 - 1992)
- Saratoga, NY (US) (1992 - 1996)
- Ft Lauderdale, FL (US) (2001)
- Redding, CA (US) (1994 - 2002)
- Morrisonville, NY (US) (2003 - 2005)
- Jefferson, GA (US) (2003 - 2005)
- Fredericksburg, VA (US) (2006)
- Mayfield Heights, OH (US) (2010)
- Pepper Pike, OH (US) (2010 - 2012)
- Clev. Hts., OH (US) (2014)
- Isabella, MI (US) (2014)
- Glendale, AZ (US) (2015)
- Tampa, FL (US) (2015)
- Mt. Pleasant, MI (US) (2017)
- Charlotte, NC (US) (2013 - 2018)
- Lafayette, LA (US) (2016 - 2020)
- Windsor, CT (US) (2021 - 2023)
- Avon, CT (US) (2023)
- Cleveland Heights, OH (US) (2014 - 2024)
Company Filing History:
17 out of 1,306 
5 out of 8,684 
4 out of 113 
Years Active: 1991-2025
Title: The Innovative Contributions of David L. Wilson
Introduction
David L. Wilson, a distinguished inventor based in Cleveland Heights, Ohio, holds an impressive portfolio of 52 patents. His work primarily revolves around the field of ophthalmology, particularly focusing on the assessment and segmentation of corneal endothelial cells. Through his groundbreaking inventions, Wilson has made significant contributions to improving the prognosis and outcomes of keratoplasty procedures.
Latest Patents
Among his latest innovations are two notable patents. The first is titled "Assessment of Endothelial Cells and Corneas at Risk from Ophthalmological Images." This invention details a method for determining the prognosis for keratoplasty based on segmented endothelial cells. The technology involves accessing an optical microscopy image of a patient’s corneal endothelial cells, segmenting those cells, calculating features based on the segmentation, and ultimately generating a prognosis for the keratoplasty using a trained model.
The second patent, "Automated Segmentation and Guided Correction of Endothelial Cell Images," enhances the process of identifying and correcting corneal endothelial cell images through automation. This process includes pre-processing images to rectify shading or illumination artifacts, followed by the segmentation of endothelial cells using a trained deep learning model. The results are then displayed via a graphical user interface, significantly improving the efficiency and accuracy of endothelial cell assessments.
Career Highlights
Wilson’s career is marked by his innovative approach to utilizing technology in medical imaging. His work at Case Western Reserve University has been pivotal, contributing to advancements in the understanding and treatment of corneal conditions. His expertise in developing tools that leverage optical microscopy images showcases his dedication to enhancing patient care and medical research.
Collaborations
Throughout his career, Wilson has collaborated with notable professionals in his field, including Jay Krajewski and Kevin Gerald Meyer. These partnerships have further enriched his research and developments, allowing for a collaborative approach to solving complex challenges in ophthalmology.
Conclusion
David L. Wilson’s contributions to ophthalmology through his numerous patents demonstrate the profound impact of innovation in medicine. His advanced methodologies in assessing corneal endothelial cells not only improve surgical outcomes but also pave the way for future research and inventions in the field. As he continues to innovate, the medical community eagerly anticipates the potential advancements that will emerge from his work.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.